1 |
Salama G, Miedougue M, Rouxaud P, et al. Evaluation of pleural cypra 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions. Br J Cancer 1998;77:472-6
|
2 |
Villena V, Lopez EA, Echave J, Mart MP, Ortuno B, Estenoz J. Diagnostic value of CA549 in pleural fluid. Comparison with CEA, CA15.3 and CA72.4. Lung Cancer 2003;40:289-94
DOI
PUBMED
ScienceOn
|
3 |
Hirsch FR, Franklin WA, Gazdar AF, Bunn PA Jr. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 2001;7:5-22
PUBMED
|
4 |
Vansteenkiste JF, Paul RDL, Georges JD, et al. Survival and prognostoic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Ann Thorac Surg 1977;63:1441-80
DOI
ScienceOn
|
5 |
Niklinski J, Furman M. Clinical tumor markers in lung cancer. Eur J Cancer Prev 1995;4:129-38
DOI
PUBMED
ScienceOn
|
6 |
Cohen S, Hossain S. Primary carcinoma of the lung: a review of 417 histologically proved cases. Dis Chest 1966;49:67-73
DOI
PUBMED
|
7 |
Johnston WW. The malignant pleural effusion: a review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 1985;56:905-9
DOI
ScienceOn
|
8 |
Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K. Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res 1997;3:47-50
PUBMED
|
9 |
Hotta K, Segawa Y, Takigawa N, et al. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical stage I patients with non-small cell lung cancer. Cancer Res 2000;20:2177-80
|
10 |
Ohta Y, Shimizu Y, Matsumoto I, Watanabe G. Management of malignant effusion by multimodality treatment including the use of paclitaxel administerd by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis. J Exp Clin Cancer Res 2006;25:15-9
PUBMED
|
11 |
Sahn SA, Good JTJ. Pleural fluid pH in malignant effusions. diagnostic, prognostic, and therapeutic implications. Ann Intern Med 1988;108:345-9
DOI
PUBMED
ScienceOn
|
12 |
Sasaki T, Yasuda H, Nakayama K, et al. Pleurodesis with carboplatin in elderly patients with malignant pleural effusion and lung adenocarcinoma. J Am Geriatr Soc 2006;54:722-3
DOI
PUBMED
ScienceOn
|
13 |
Soh J, Toyooka S, Aoe K, et al. Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer. Int J Cancer 2006;119:2353-8
DOI
ScienceOn
|
14 |
Good JT, Taryle DA, Shan SA. The pathogenesis of low glucose, low pH malignant effusions. Am Rev Respir Dis 1985;131:737-41
PUBMED
|